Commodore Capital Lp - Net Worth and Insider Trading
Commodore Capital Lp Net Worth
The estimated net worth of Commodore Capital Lp is at least $246 Million dollars as of 2024-11-05. Commodore Capital Lp is the 10% Owner of Vera Therapeutics Inc and owns about 4,400,000 shares of Vera Therapeutics Inc (VERA) stock worth over $200 Million. Commodore Capital Lp is the 10% Owner of Enliven Therapeutics Inc and owns about 1,448,640 shares of Enliven Therapeutics Inc (ELVN) stock worth over $40 Million. Commodore Capital Lp is also the 10% Owner of Vistagen Therapeutics Inc and owns about 1,575,000 shares of Vistagen Therapeutics Inc (VTGN) stock worth over $5 Million. Besides these, Commodore Capital Lp also holds Satsuma Pharmaceuticals Inc (STSA) . Details can be seen in Commodore Capital Lp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Commodore Capital Lp has not made any transactions after 2024-01-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Commodore Capital Lp
Commodore Capital Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Commodore Capital Lp owns 5 companies in total, including Satsuma Pharmaceuticals Inc (STSA) , Enliven Therapeutics Inc (ELVN) , and Ambrx Biopharma Inc (AMAM) among others .
Click here to see the complete history of Commodore Capital Lp’s form 4 insider trades.
Insider Ownership Summary of Commodore Capital Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STSA | Satsuma Pharmaceuticals Inc | 2022-11-14 | 10 percent owner |
| ELVN | Enliven Therapeutics Inc | 2023-02-23 | 10 percent owner |
| AMAM | Ambrx Biopharma Inc | 2023-02-23 | 10 percent owner |
 | | 2024-01-10 | 10 percent owner |
| | 2023-08-07 | 10 percent owner |
Commodore Capital Lp Latest Holdings Summary
Commodore Capital Lp currently owns a total of 4 stocks. Among these stocks, Commodore Capital Lp owns 4,400,000 shares of Vera Therapeutics Inc (VERA) as of January 10, 2024, with a value of $200 Million and a weighting of 81.42%. Commodore Capital Lp owns 1,448,640 shares of Enliven Therapeutics Inc (ELVN) as of February 23, 2023, with a value of $40 Million and a weighting of 16.32%. Commodore Capital Lp also owns 1,575,000 shares of Vistagen Therapeutics Inc (VTGN) as of August 7, 2023, with a value of $5 Million and a weighting of 2.06%. The other 1 stocks Satsuma Pharmaceuticals Inc (STSA) have a combined weighting of 0.21% among all his current holdings.
Latest Holdings of Commodore Capital Lp
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VERA | Vera Therapeutics Inc | 2024-01-10 | 4,400,000 | 45.51 | 200,244,000 |
| ELVN | Enliven Therapeutics Inc | 2023-02-23 | 1,448,640 | 27.70 | 40,127,328 |
| VTGN | Vistagen Therapeutics Inc | 2023-08-07 | 1,575,000 | 3.22 | 5,071,500 |
| STSA | Satsuma Pharmaceuticals Inc | 2022-11-14 | 461,286 | 1.10 | 507,415 |
Holding Weightings of Commodore Capital Lp
Commodore Capital Lp Form 4 Trading Tracker
According to the SEC Form 4 filings, Commodore Capital Lp has made a total of 2 transactions in Vera Therapeutics Inc (VERA) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Vera Therapeutics Inc is the sale of 1,050,000 shares on January 10, 2024, which brought Commodore Capital Lp around $19 Million.
According to the SEC Form 4 filings, Commodore Capital Lp has made a total of 1 transactions in Enliven Therapeutics Inc (ELVN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Enliven Therapeutics Inc is the acquisition of 622 shares on February 23, 2023, which cost Commodore Capital Lp around $13,722.
According to the SEC Form 4 filings, Commodore Capital Lp has made a total of 1 transactions in Vistagen Therapeutics Inc (VTGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Vistagen Therapeutics Inc is the acquisition of 775,756 shares on August 7, 2023, which cost Commodore Capital Lp around $18 Million.
More details on Commodore Capital Lp's insider transactions can be found in the Insider Trading History of Commodore Capital Lp table.Insider Trading History of Commodore Capital Lp
- 1
Commodore Capital Lp Trading Performance
GuruFocus tracks the stock performance after each of Commodore Capital Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Commodore Capital Lp is -16.22%. GuruFocus also compares Commodore Capital Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Commodore Capital Lp within 3 months outperforms 1 times out of 13 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Commodore Capital Lp's insider trading performs compared to the benchmark.
Performance of Commodore Capital Lp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.6 | | | | | |
| Relative Return to S&P 500(%) | -14.52 | | | | | |
Commodore Capital Lp Ownership Network
Ownership Network List of Commodore Capital Lp
Ownership Network Relation of Commodore Capital Lp
Commodore Capital Lp Owned Company Details
What does Satsuma Pharmaceuticals Inc do?
Who are the key executives at Satsuma Pharmaceuticals Inc?
Commodore Capital Lp is the 10 percent owner of Satsuma Pharmaceuticals Inc. Other key executives at Satsuma Pharmaceuticals Inc include 10 percent owner Shin Nippon Biomedical Laboratories, Ltd. , director & 10 percent owner Ken Takanashi , and 10 percent owner Braden Michael Leonard .
Satsuma Pharmaceuticals Inc (STSA) Insider Trades Summary
Over the past 18 months, Commodore Capital Lp made no insider transaction in Satsuma Pharmaceuticals Inc (STSA). Other recent insider transactions involving Satsuma Pharmaceuticals Inc (STSA) include a net purchase of 30,477,313 shares made by Shin Nippon Biomedical Laboratories, Ltd. , and a net purchase of 22,053,581 shares made by Ken Takanashi .
In summary, during the past 3 months, insiders sold 0 shares of Satsuma Pharmaceuticals Inc (STSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Satsuma Pharmaceuticals Inc (STSA) were sold and 52,530,894 shares were bought by its insiders, resulting in a net purchase of 52,530,894 shares.
Satsuma Pharmaceuticals Inc (STSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Satsuma Pharmaceuticals Inc Insider Transactions
Commodore Capital Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Commodore Capital Lp. You might contact Commodore Capital Lp via mailing address: 444 Madison Avenue, 35th Floor, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
